Looking For The New Lantus: Next-Gen Diabetes Hopefuls Defy Risks
This article was originally published in Start Up
Executive Summary
The diabetes market presents competitive, commercial, and regulatory challenges, but its size and breadth spur emerging biotechs to develop an ever-wider range of treatments and technologies.